A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
Clinical trial NCT07092865 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07092865
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-06
- Primary completion
- 2027-01-12
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.